ACR Meeting Abstracts

ACR Meeting Abstracts

Abstract Number: 3123

Rare Mediterranean Fever (MEFV) Gene Polymorphisms Are Associated with Ankylosing Spondylitis in Turkish and Iranian Population

Zhixiu Li1, Servet Akar2, Handan Yarkan3, Pinar Cetin3, Gerçek Can3, Gökce Kenar3, Omer Nuri Pamuk4, Yavuz Pehlivan5, Katie Cremin6, Erika De Guzman1, Jessica Harris1, Ahmad Reza Jamshidi7, Mahdi Vojdanian7, Nooshin Ahmadzadeh7, Mahdi Mahmoudi7, Matthew A. Brown1 and Nurullah Akkoc3, 1Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 2Department of Rheumatology, İzmir Katip Çelebi University, School of Medicine, İzmir, Turkey, İzmir, Turkey, 3Department of Rheumatology, Dokuz Eylul University, Faculty of Medicine, İzmir, Turkey, İzmir, Turkey, 4Department of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey, Edirne, Turkey, 5Department of Rheumatology, Uludag University Medical Faculty, Bursa, Turkey, Bursa, Turkey, 6The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 7Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran (Islamic Republic of)

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: , , ,

Session Information

Date: Wednesday, November 16, 2016

Title: Genetics, Genomics and Proteomics II

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Ankylosing spondylitis (AS) is a highly heritable inflammatory arthritis common in both Turkish and Iranian populations. Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disease that usually occurs in people of Mediterranean origin. MEFV, a known FMF-associated gene, is a candidate gene for AS, because of increased co-familiality of AS and FMF, and suggestive association of MEFV with AS in candidate gene studies. Here we studied Turkish and Iranian case-control cohorts to identify AS susceptibility loci and also examine the association between MEFV and AS.

Methods: A genome wide association study was performed in 1001 Turkish AS patients and 1011 Turkish controls and also 479 Iranian AS patients and 830 Iranian controls, using Illumina Infinium CoreExome chips. Standard quality control and population stratification identification and control measures were applied (lambda1000 in Turkish, Iranian and combined datasets 1.039, 1.025 and 1.025 respectively).

Results: In this study we identified two non-MHC loci, MEFV and USP8 reaching genome-wide significance (p < 5×10-8), and fourteen suggestive loci (10-5 < p <5×10-8), in the combined cohort. The lead MEFV SNP rs61752717 (M694V, p = 7.6×10-12, OR = 5.3) is a rare coding variant (MAF=0.011 in Turkish controls) and also the most penetrant FMF-associated variant. This lead SNP also shows significant association with AS in Iranian cohort (p = 0.042, OR = 2.9), and in the combined dataset is very strongly AS-associated (p = 1.5×10-13, OR = 4.9). Three coding variants in MEFV were significantly associated with AS (P369S, R408Q and M694V). AS cases with MEFV rs61752717 variants did not themselves have FMF, and had similar disease manifestations to non-carriers. This study confirms the previous identification of USP8 as an AS-associated locus (exm1161045, p = 8.0×10-14, OR = 0.58 in combined dataset), and at previously reported AS-associated loci including HLA-B, ERAP1 and 2p15.

Conclusion: This study provides definitive evidence of the association of rare MEFV variants with AS, and confirms that FMF and AS have overlapping aetiopathogenic mechanisms. The association of MEFV in these populations has the highest odds ratio for AS of any non-MHC genetic variant confirmed at genome-wide significance to date. Functionally important MEFV mutations such as M694V have been demonstrated to lead to dysregulated inflammasome function and excessive IL-1b function. Given that IL-1 inhibition is effective in FMF, it will be interesting to study whether AS cases carrying FMF-associated MEFV variants also benefit from such therapy.

Disclosure: Z. Li, None; S. Akar, None; H. Yarkan, None; P. Cetin, None; G. Can, None; G. Kenar, None; O. N. Pamuk, None; Y. Pehlivan, None; K. Cremin, None; E. D. Guzman, None; J. Harris, None; A. R. Jamshidi, None; M. Vojdanian, None; N. Ahmadzadeh, None; M. Mahmoudi, None; M. A. Brown, None; N. Akkoc, Pfizer Inc, 2.

To cite this abstract in AMA style:

Li Z, Akar S, Yarkan H, Cetin P, Can G, Kenar G, Pamuk ON, Pehlivan Y, Cremin K, Guzman ED, Harris J, Jamshidi AR, Vojdanian M, Ahmadzadeh N, Mahmoudi M, Brown MA, Akkoc N. Rare Mediterranean Fever (MEFV) Gene Polymorphisms Are Associated with Ankylosing Spondylitis in Turkish and Iranian Population [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/rare-mediterranean-fever-mefv-gene-polymorphisms-are-associated-with-ankylosing-spondylitis-in-turkish-and-iranian-population/. Accessed .

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rare-mediterranean-fever-mefv-gene-polymorphisms-are-associated-with-ankylosing-spondylitis-in-turkish-and-iranian-population/